Market Access
Understanding the evolution of container closure integrity testing
At different stages of the drug lifecycle, the minimum provision for …
19732 items found
News
Report warns economic instability has hit UK drug discovery
A UK report has said that inflation and geopolitical instability have …
Sales & Marketing
Sponsored
12 Questions with Pilar de la Rocha Mur
Pilar de la Rocha Mur is Head of Clinical Operations EMEA (Europe, …
News
New metric predicts burden of participating in trials
After patients enrol in clinical trials, regular assessments and …
News
Spectral AI nears first sales of wound care system
Spectral AI is on the brink of becoming a commercial-stage company, …
News
Regeneron gene therapy restores hearing in deaf child
Regeneron’s gene therapy for otoferlin-related hearing loss – a …
R&D
The end of drug shortages begins with data transparency
For more than 15 years, shortages of critical drugs — from oncology …
R&D
Pharma gets ruthless as job losses mount across industry
The industry is showing its teeth, as companies have started slashing …
News
RNA blood test may predict antidepressant response
Selective serotonin reuptake inhibitors (SSRIs) are the first-line …
Patients
Clinical trials: Their design, location, and, potentially, their simulation
Clinical trials, their design and location, and these days their …
News
FDA sets June adcomm date for Lilly’s Alzheimer’s drug
The FDA has confirmed that it will convene an advisory committee …
News
Zenas’ $200m round heads big clutch of bio financings
Our round-up of recent biotech financings is headed by a sizeable …
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
Patients
Partner Content
How walking in a patient's shoes adds value to your patient ...
Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?
